
21-deacetyldeflazacort
CAS No. 13649-57-5
21-deacetyldeflazacort ( —— )
产品货号. M27940 CAS No. 13649-57-5
21-脱乙酰地夫可特是地夫可特的代谢物,地夫可特是一种全身性皮质类固醇,也是泼尼松龙的衍生物。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1337 | 有现货 |
![]() ![]() |
10MG | ¥1985 | 有现货 |
![]() ![]() |
25MG | ¥3370 | 有现货 |
![]() ![]() |
50MG | ¥4803 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称21-deacetyldeflazacort
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述21-脱乙酰地夫可特是地夫可特的代谢物,地夫可特是一种全身性皮质类固醇,也是泼尼松龙的衍生物。
-
产品描述21-deacetyldeflazacort is a metabolite of Deflazacort, which is a systemic corticosteroid and a derivative of prednisolone.(In Vitro):21-deacetyldeflazacort displaces [3H]dexamethasone from its cytosol receptor sites in rat kidney, thymus and liver in vitro.(In Vivo):21-deacetyldeflazacort inhibited 48-h homologous passive cutaneous anaphylaxis in rats, but had no significant effects on active systemic anaphylaxis in mice, on the Schultz-Dale reaction in the isolated guinea-pig trachea or on compound 48/80-induced histamine release in rat peritoneal mast cells. 21-deacetyldeflazacort inhibited reversed cutaneous anaphylaxis in rats and the Arthus reaction in mice.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number13649-57-5
-
分子量399.487
-
分子式C23H29NO5
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 250 mg/mL (625.81 mM)
-
SMILESCC1=N[C@@]2([C@@H](C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)O1)C(=O)CO
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Thielen LA, et al. Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action. Cell Metab. 2020 Sep 1;32(3):353-365.e8.
产品手册




关联产品
-
Ophiopogonin B
Ophiopogonin B 具有抗肿瘤活性,是 PI3K/Akt 的潜在抑制剂。
-
Eledoisin Related Pe...
Eledoisin相关肽(2TFA)是速激肽受体配体。P物质和eledoisin相关肽对呼吸神经元和反射性中间神经元有兴奋作用,但与谷氨酸诱导的作用相比,兴奋起效较慢,放电后持续时间较长。
-
1-Methoxyphaseollidi...
1-Methoxyphaseollidin exhibits anti-Helicobacter pylori activity against the CLAR and AMOX-resistant strain as well as four CLAR (AMOX)-sensitive strains.